|
|
Targeted Cancer Therapies
Links to news articles on
Targeted Cancer Therapies
.
New Therapies Target Cancer -- Mar 7, 2006
Several small molecule and antibody-based targeted cancer therapies are on the market and others are in the pipeline. Determining ... Drug Discovery & Development (subscription),
TRACON Pharmaceuticals Assembles Industry-Leading Management Team ... -- Mar 15, 2006
SAN DIEGO, March 15 /PRNewswire/ -- TRACON Pharmaceuticals, Inc., an emerging biopharmaceutical company developing targeted cancer therapies, today announced ... Yahoo! News (press release)
Xencor Data Published in PNAS Show Engineering the ''Fc'' Region ... -- Mar 7, 2006
Fc" region of monoclonal antibodies (mAbs) increases their toxicity to cancer cells, potentially improving the utility of targeted cancer therapies, according ... Genetic Engineering News,
Skyepharma hires UBS for sale -- Mar 11, 2006
A lot of new products are coming in, such as vaccines and targeted cancer therapies, and are all injectable – so there is a need for capacity in that space ... Business Online,
NCI Media Relations Branch -- 25 Jan 2006
Reuben Shaw, Ph.D. (Salk): How decoding circuitry underlying tumor development may lead to targeted cancer therapies Dwayne Stupack, Ph.D. (Moores UCSD Cancer ... Nieuwsbank (persbericht),
NCI Sponsors Science Writers’ Seminar: “The Basics of Clinical ... -- Jan 24, 2006
...medicines. Reuben Shaw, Ph.D. (Salk): How decoding circuitry underlying tumor development may lead to targeted cancer therapies. Dwayne ... WebWire (press release),
Targeted cancer therapies: Another step forward -- Dec 22, 2005
While it is clear that the treatment of cancer has already begun to undergo a paradigm shift with the inclusion of innovative targeted therapies into current ... News-Medical.net,
Targeted cancer therapies: another step forward -- Dec 23, 2005
22 Dec 2005, 17:16 GMT - While innovative targeted therapies have brought progress in the treatment of cancer, it would be wrong to assume that these products ... Pharmaceutical Business Review
Your money or your life for cancer sufferers -- Jan 6, 2006
Approved in the United States in 1998, it was one of the first targeted cancer therapies. It targets a protein called human growth factor 2 (HER2). ... New Zealand Herald,
Cell Stress Protein Linked To Aggressive Breast Cancer -- Jan 9, 2006
...suggesting that alphaB-crystallin may be a useful molecular marker to identify women with aggressive breast cancer and to develop new targeted cancer therapies ... Science Daily (press release)
DMetrix's "80 Microscopes in One Instrument" Is Now the World's ... -- Jan 3, 2006
...sections of cancers. "Such analyses will expedite drug discovery and the development of targeted cancer therapies. There are many ... Market Wire (press release)
Targeted cancer therapies: another step forward -- 23 Dec 2005
22 Dec 2005, 17:16 GMT - While innovative targeted therapies have brought progress in the treatment of cancer, it would be wrong to assume that these products ... Pharmaceutical Business Review
Targeted cancer therapies: Another step forward -- Dec 22, 2005
While it is clear that the treatment of cancer has already begun to undergo a paradigm shift with the inclusion of innovative targeted therapies into current ... News-Medical.net,
DATAMONITOR: Targeted Cancer Therapies: Another step forward -- Dec 22, 2005
LONDON, December 22, 2005- While it is clear that the treatment of cancer has already begun to undergo a paradigm shift with the inclusion of innovative ... PharmaLive.com (press release),
Gene mapping project promises new targeted cancer therapies -- Dec 14, 2005
They hope the work will enable them to replicate the successes of the few targeted cancer therapies such as Herceptin, useful against one type of breast cancer ... News-Medical.net,
Lung cancer in women -- Dec 11, 2005
Researchers have found that lung cancer patients with mutations in EGFR tend to respond better to Iressa, one of the newer, targeted cancer therapies. ... ITP.net,
US launches cancer gene mapping project -- Dec 13, 2005
They hope to lay the groundwork for replicating the successes of a few targeted cancer therapies such as Genentech Inc's Herceptin, useful against one type of ... Reuters
Monogram's eTag(TM) Technology Featured in British Journal of ... -- Dec 1, 2005
The paper reports a study of correlations between skin toxicity, a common side effect of certain targeted cancer therapies but not others, and the dimerization ... PR Newswire (press release),
Merck reveals plans for rebirth -- Dec 16, 2005
...on nine specific areas: Alzheimer's disease, atherosclerosis, cardiovascular disease, diabetes, novel vaccines, obesity, targeted cancer therapies, pain and ... NorthJersey.com,
Genzyme Launches Colorectal Cancer Test to Determine Appropriate ... -- Dec 6, 2005
Genzyme Genetics has launched several major new cancer tests this year, all of which help to identify patients likely to respond to targeted cancer therapies. ... Yahoo! News (press release)
HEALTH & FITNESS -- Dec 6, 2005
...drugs more tumour-specific. Targeted cancer therapies use drugs that block the growth and spread of cancer. They interfere with ... The Tribune,
Businessman gives $20 million -- Dec 5, 2005
...interdisciplinary teams will work in promising areas of cancer research — including proton therapy and molecular imaging, targeted cancer therapies where ... San Antonio Express (subscription),
Monogram Presents Clinical Data on eTag(TM) Assay's Potential to ... -- Nov 15, 2005
...looking, including statements regarding the ability of assays based on the eTag technology to predict individual patient response to targeted cancer therapies. ... Yahoo! News (press release)
Monogram Biosciences Announces Numerous Presentations of eTag(TM) ... -- Nov 14, 2005
Studies Demonstrate Potential of eTag Assay to Predict Individual Patient Response to Targeted Cancer Therapies SOUTH SAN FRANCISCO, Calif., Nov. ... PR Newswire (press release),
Seattle Genetics to Present on ADC Technology at the AACR-NCI ... -- Nov 14, 2005
Genetics and our collaborators demonstrate some of the key advances being made with our technology to empower the next generation of targeted cancer therapies ... Genetic Engineering News,
Cancer screensaver program shows potential -- Oct 26, 2005
Graham Richards, Chairman of the Oxford University Chemistry Department and Dr. Daniel Von Hoff, Director of the NFCR Center for Targeted Cancer Therapies at ... Phoenix Business Journal,
MASS Opportunities: A Biotechnology Investment Conference ... -- Nov 2, 2005
...mail: geldridge@therionbio.com Web: www.therionbio.com Therion Biologics Corporation is a leader in the development of novel targeted cancer therapies designed ... Genetic Engineering News,
Reata Drug Effective in Preventing Liver Cancer -- Nov 4, 2005
Cancer Center. These agents are potential first-in-class targeted cancer therapies with a unique mechanism of action. They bind ... PR Newswire (press release),
Merck in cancer research deal with Aveo -- Nov 2, 2005
...is joining with privately-held Aveo Pharmaceuticals Inc. to develop certain targeted cancer therapies, Aveo said Wednesday. The ... BusinessWeek
Third Wave and Genzyme Genetics Announce Preferred Marketing ... -- Oct 27, 2005
...launched several major new cancer diagnostic tests this year, all of which help to identify which patients are likely to respond to targeted cancer therapies. ... PR Newswire (press release),
Monogram Announces Third Quarter 2005 Financial Results -- Oct 24, 2005
...launch of our first commercial eTag assay in oncology, a test panel measuring activated EGF receptors related to approved targeted cancer therapies during 2006 ... PR Newswire (press release),
Merck in Cancer Research Deal With Aveo -- Nov 2, 2005
Pharmaceutical firm Merck & Co. is joining with privately-held Aveo Pharmaceuticals Inc. to develop certain targeted cancer therapies, Aveo said Wednesday. ... Forbes
Molecular Profiling Institute Secures $7.5 million in Series B ... -- Oct 29, 2005
...to develop additional assays through collaborations in clinical trials that indicate populations of patients who may best respond to targeted cancer therapies. ... Biotech Intelligence (press release),
Schering AG and Sonus Pharmaceuticals Announce Global Licensing ... -- Oct 18, 2005
...collaboration with Sonus Pharmaceuticals strategically complements our innovative and extensive internal pipeline of systemic and targeted cancer therapies and ... PR Newswire (press release),
pSivida to present at Lux Executive Summit in Cambridge ... -- Oct 24, 2005
...multiple potential applications across the high growth healthcare sector, including controlled release drug delivery, targeted cancer therapies (including ... PharmaLive.com (press release),
|
|
|
|
More information on
Targeted Cancer Therapies from the National Cancer Institute
Targeted cancer therapies use drugs that block the growth and spread of cancer. They interfere with specific molecules involved in carcinogenesis (the process by which normal cells become cancer cells) and tumor growth. Because scientists call these molecules “molecular targets,” these therapies are sometimes called “molecular-targeted drugs,” “molecularly targeted therapies,” or other similar names. By focusing on molecular and cellular changes that are specific to cancer, targeted cancer therapies may be more effective than current treatments and less harmful to normal cells.
Most targeted cancer therapies are in preclinical testing (research with animals), but some are in clinical trials (research studies with people), or have been approved by the U.S. Food and Drug Administration (FDA). Targeted cancer therapies are being studied for use alone, in combination with each other, and in combination with other cancer treatments, such as chemotherapy.
More from the National Cancer Institute
|
|
